• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝切除成功的预测因素:肝脏去唾液酸糖蛋白受体分析的预后价值

Predictors of successful hepatic resection: prognostic usefulness of hepatic asialoglycoprotein receptor analysis.

作者信息

Kokudo Norihiro, Vera David R, Tada Keiichiro, Koizumi Mitsuru, Seki Makoto, Matsubara Toshiki, Ohta Hirotoshi, Yamaguchi Toshiharu, Takahashi Takashi, Nakajima Toshifusa, Muto Tetsuichiro

机构信息

Department of Surgery, Cancer Institute Hospital, 1-37-1 Kami-Ikebukuro, Toshima-ku, Tokyo, Japan 170-8455.

出版信息

World J Surg. 2002 Nov;26(11):1342-7. doi: 10.1007/s00268-002-6262-3. Epub 2002 Sep 26.

DOI:10.1007/s00268-002-6262-3
PMID:12297928
Abstract

To test the clinical usefulness of hepatic asialogycoprotein receptor analysis in liver surgery, we have conducted univariate and multivariate analysis for the detection of cirrhotic patients and prediction of morbidity after hepatic resection. Liver scintigraphy using technetium 99m-labeled asialoglycoprotein analog (TcGSA), ICG test, and CT hepatic volumetry were undertaken in 158 surgical patients including 111 who underwent hepatic resection. Hepatic functional parameters including Child-Pugh score, indocyanine green retention at 15 minutes (ICG-R15), clearance index (HH15), receptor index (LHL15), receptor concentration ([R]0), total hepatic receptor amount (R0) and hepatic parenchymal volume (HPV) were compared among patients with normal, cirrhotic, and non-cirrhotic damaged liver. Preoperative hepatic functional parameters, resected parenchymal fraction (RPf), operative blood loss, and total receptor amount of the remnant liver (R0-remnant) were compared between patients with and without signs of postoperative liver failure. All parameters but HPV were significantly different among patients with normal, cirrhotic, and noncirrhotic damaged liver. The multivariate analysis selected two significant (p <0.05) parameters, [R]0 and Child-Pugh score for the detection of liver cirrhosis. Of the 111 patients who underwent resection, 14 developed transient signs of postoperative liver failure. Of the parameters tested, presence of liver cirrhosis, LHL15, R0, intraoperative blood loss, and R0-remnant were significantly different between patients with and without signs of postoperative liver failure (p <0.05). The multivariate logistic regression analysis selected only R0-remnant as a significant (p = 0.022) parameter for the prediction of liver failure. The morbidity rate in patients with R0-remnant under 0.05 mmoles was 100%, and the rate decreased in inverse proportion to R0-remnant. In conclusion, combining the ASGP-R concentration ([R]0) and the Child-Pugh score best detected liver cirrhosis in surgical candidates. Cirrhotic patients and patients with a low R0-remnant are at higher risk for postoperative liver failure. The present study confirms the usefulness of hepatic asialogycoprotein receptor analysis in liver surgery.

摘要

为了测试肝脏去唾液酸糖蛋白受体分析在肝脏手术中的临床实用性,我们对肝硬化患者的检测以及肝切除术后发病率的预测进行了单因素和多因素分析。对158例外科手术患者进行了使用锝99m标记的去唾液酸糖蛋白类似物(TcGSA)的肝脏闪烁扫描、吲哚菁绿试验(ICG试验)和CT肝脏容积测量,其中111例患者接受了肝切除术。比较了正常肝脏、肝硬化肝脏和非肝硬化受损肝脏患者的肝功能参数,包括Child-Pugh评分、15分钟吲哚菁绿潴留率(ICG-R15)、清除指数(HH15)、受体指数(LHL15)、受体浓度([R]0)、肝脏总受体量(R0)和肝实质体积(HPV)。比较了有和没有术后肝衰竭迹象患者的术前肝功能参数、切除的实质部分比例(RPf)、术中失血量和残余肝脏的总受体量(R0-残余)。除HPV外,正常肝脏、肝硬化肝脏和非肝硬化受损肝脏患者的所有参数均有显著差异。多因素分析选择了两个显著(p<0.05)参数,即[R]0和Child-Pugh评分用于肝硬化的检测。在111例接受切除术的患者中,14例出现了术后肝衰竭的短暂迹象。在所测试的参数中,有和没有术后肝衰竭迹象的患者之间,肝硬化的存在、LHL15、R0、术中失血量和R0-残余有显著差异(p<0.05)。多因素逻辑回归分析仅选择R0-残余作为预测肝衰竭的显著(p = 0.022)参数。R0-残余低于0.05毫摩尔的患者发病率为100%,发病率与R0-残余成反比下降。总之,联合去唾液酸糖蛋白受体浓度([R]0)和Child-Pugh评分能最好地检测手术候选者中的肝硬化。肝硬化患者和R0-残余低的患者术后肝衰竭风险更高。本研究证实了肝脏去唾液酸糖蛋白受体分析在肝脏手术中的实用性。

相似文献

1
Predictors of successful hepatic resection: prognostic usefulness of hepatic asialoglycoprotein receptor analysis.肝切除成功的预测因素:肝脏去唾液酸糖蛋白受体分析的预后价值
World J Surg. 2002 Nov;26(11):1342-7. doi: 10.1007/s00268-002-6262-3. Epub 2002 Sep 26.
2
Preoperative estimation of remnant hepatic function using fusion images obtained by (99m)Tc-labelled galactosyl-human serum albumin liver scintigraphy and computed tomography.术前应用放射性核素标记半乳糖白蛋白肝闪烁扫描和计算机体层摄影融合图像评估残余肝功能。
Br J Surg. 2010 Jun;97(6):934-44. doi: 10.1002/bjs.7025.
3
Recovery of hepatic asialoglycoprotein receptors after major hepatic resection.肝大部切除术后肝脏去唾液酸糖蛋白受体的恢复
J Nucl Med. 1999 Jan;40(1):137-41.
4
Predictability of Tc-Galactosyl Human Serum Albumin Scintigraphy for Posthepatectomy Liver Failure.Tc-半乳糖基人血清白蛋白闪烁显像对肝切除术后肝衰竭的预测性。
AJR Am J Roentgenol. 2018 Jan;210(1):158-165. doi: 10.2214/AJR.17.18411. Epub 2017 Oct 12.
5
Preoperative assessment of liver function.肝功能的术前评估。
Surg Clin North Am. 2004 Apr;84(2):355-73. doi: 10.1016/S0039-6109(03)00224-X.
6
Comparison of Tc-99m-GSA scintigraphy with hepatic fibrosis and regeneration in patients with hepatectomy.肝切除患者中锝-99m-甘氨酰双乙酸二乙胺(Tc-99m-GSA)闪烁扫描术与肝纤维化及肝再生的比较
Ann Nucl Med. 2003 May;17(3):227-33. doi: 10.1007/BF02990026.
7
Clinical application of TcGSA.TcGSA的临床应用
Nucl Med Biol. 2003 Nov;30(8):845-9. doi: 10.1016/s0969-8051(03)00113-6.
8
Postoperative assessment of hepatic asialoglycoprotein receptor function with Tc-99m GSA: the safety margin of resection size in living donor liver transplantation.用锝-99m GSA进行肝脏去唾液酸糖蛋白受体功能的术后评估:活体肝移植中切除大小的安全边际
Ann Transplant. 2015 Jan 26;20:51-8. doi: 10.12659/AOT.892490.
9
Natural course of the remnant hepatic functional reserve as estimated by technetium-99m-galactosyl human serum albumin scintigraphy after a hepatectomy.肝切除术后 99mTc-半乳糖白蛋白闪烁扫描测定残肝功能性储备的自然病程。
J Gastroenterol. 2010 Mar;45(3):308-16. doi: 10.1007/s00535-009-0144-5. Epub 2009 Nov 7.
10
Impaired Value of 99m Tc-GSA Scintigraphy as an Independent Risk Factor for Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma.99m锝-甘氨酰双乙酸二乙酯闪烁扫描成像价值受损作为肝细胞癌患者肝切除术后肝衰竭的独立危险因素
Eur Surg Res. 2018;59(1-2):12-22. doi: 10.1159/000484044. Epub 2018 Jan 12.

引用本文的文献

1
Clearance of the liver remnant predicts short-term outcome in patients undergoing resection of hepatocellular carcinoma.肝残存量廓清预测接受肝细胞癌切除术患者的短期预后。
World J Gastroenterol. 2022 Oct 14;28(38):5614-5625. doi: 10.3748/wjg.v28.i38.5614.
2
An mALBI-Child-Pugh-based nomogram for predicting post-hepatectomy liver failure grade B-C in patients with huge hepatocellular carcinoma: a multi-institutional study.基于 mALBI-Child-Pugh 的列线图预测巨大肝细胞癌患者肝切除术后 B-C 级肝衰竭的多中心研究。
World J Surg Oncol. 2022 Jun 16;20(1):206. doi: 10.1186/s12957-022-02672-5.
3
Comparison of nuclear imaging techniques and volumetric imaging for the prediction of postoperative mortality and liver failure in patients undergoing localized liver-directed treatments: a systematic review.

本文引用的文献

1
Recovery of hepatic asialoglycoprotein receptors after major hepatic resection.肝大部切除术后肝脏去唾液酸糖蛋白受体的恢复
J Nucl Med. 1999 Jan;40(1):137-41.
2
A consensus conference on prognostic studies in hepatology.肝脏病学预后研究共识会议。
J Hepatol. 1999 Jan;30(1):171-2. doi: 10.1016/s0168-8278(99)80023-3.
3
Diagnostic performance of a receptor-binding radiopharmacokinetic model.一种受体结合放射性药物动力学模型的诊断性能
核成像技术与容积成像在预测接受局部肝脏定向治疗患者术后死亡率和肝衰竭中的比较:一项系统评价
EJNMMI Res. 2021 Aug 21;11(1):80. doi: 10.1186/s13550-021-00816-4.
4
Prognostic value of future liver remnant LU15 index of 99mTc-galactosyl serum albumin scintigraphy for predicting posthepatectomy liver failure.99mTc-半乳糖白蛋白闪烁显像的未来肝脏残留 LU15 指数对预测肝切除术后肝衰竭的预后价值。
PLoS One. 2021 Feb 23;16(2):e0247675. doi: 10.1371/journal.pone.0247675. eCollection 2021.
5
Nuclear imaging methods for the prediction of postoperative morbidity and mortality in patients undergoing localized, liver-directed treatments: a systematic review.用于预测接受局部肝脏定向治疗患者术后发病率和死亡率的核成像方法:一项系统综述
EJNMMI Res. 2020 Sep 4;10(1):101. doi: 10.1186/s13550-020-00687-1.
6
Hepatic function assessment to predict post-hepatectomy liver failure: what can we trust? A systematic review.肝切除术后肝功能评估预测肝衰竭:我们可以相信什么?系统评价。
Updates Surg. 2020 Dec;72(4):925-938. doi: 10.1007/s13304-020-00859-7. Epub 2020 Aug 4.
7
Reliability of indocyanine green retention and clearance rates at 15 minutes calculated by dye-dilution cardiac output flowmetry in comparison to blood sampling in patients undergoing hepatic resection.在接受肝切除术的患者中,通过染料稀释心输出量血流测定法计算的15分钟时吲哚菁绿潴留率和清除率与采血法相比的可靠性。
Indian J Gastroenterol. 2019 Oct;38(5):441-449. doi: 10.1007/s12664-019-00994-z. Epub 2019 Dec 5.
8
A new formula to calculate the resection limit in hepatectomy based on Gd-EOB-DTPA-enhanced magnetic resonance imaging.基于钆塞酸二钠增强磁共振成像的肝切除术切除范围计算新公式。
PLoS One. 2019 Jan 25;14(1):e0210579. doi: 10.1371/journal.pone.0210579. eCollection 2019.
9
Significance of the preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin in the future remnant liver: a sequential study of regional maximal removal rate of technetium-99m-galactosyl human serum albumin in the whole liver.术前99m锝-半乳糖基人血清白蛋白在未来剩余肝脏中的区域最大清除率的意义:全肝99m锝-半乳糖基人血清白蛋白区域最大清除率的序贯研究。
Nucl Med Commun. 2019 Feb;40(2):145-152. doi: 10.1097/MNM.0000000000000950.
10
Resection for Klatskin tumors: technical complexities and results.肝门部胆管癌切除术:技术复杂性与结果
Transl Gastroenterol Hepatol. 2018 Sep 18;3:69. doi: 10.21037/tgh.2018.09.01. eCollection 2018.
J Nucl Med. 1996 Jan;37(1):160-4.
4
Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium 99m galactosyl human serum albumin.通过锝99m半乳糖基人血清白蛋白进行体内放射受体成像对肝细胞功能进行定量评估。
Hepatology. 1993 May;17(5):814-9.
5
In vivo functional imaging using receptor-binding radiopharmaceuticals. Technetium 99m-galactosyl-neoglycoalbumin as a model.使用受体结合放射性药物的体内功能成像。以锝99m-半乳糖基-新糖白蛋白作为模型。
Invest Radiol. 1993 Jan;28(1):64-70. doi: 10.1097/00004424-199301000-00018.
6
Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analog.通过受体介导摄取99m锝标记的去唾液酸糖蛋白类似物来评估肝细胞功能。
Hepatology. 1994 Oct;20(4 Pt 1):917-23. doi: 10.1002/hep.1840200421.
7
Criteria for safe hepatic resection.安全肝切除的标准。
Am J Surg. 1995 Jun;169(6):589-94. doi: 10.1016/s0002-9610(99)80227-x.
8
A multiple regression equation for prediction of posthepatectomy liver failure.一个用于预测肝切除术后肝衰竭的多元回归方程。
Ann Surg. 1984 Nov;200(5):658-63. doi: 10.1097/00000658-198411000-00018.
9
A multivariate analysis of the risk of coronary heart disease in Framingham.弗雷明汉冠心病风险的多变量分析。
J Chronic Dis. 1967 Jul;20(7):511-24. doi: 10.1016/0021-9681(67)90082-3.
10
Physical and chemical studies on ceruloplasmin. V. Metabolic studies on sialic acid-free ceruloplasmin in vivo.铜蓝蛋白的物理和化学研究。V. 体内去唾液酸铜蓝蛋白的代谢研究。
J Biol Chem. 1968 Jan 10;243(1):155-9.